These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 375960)

  • 1. Vascular symptoms in patients with primary Raynaud's phenomenon are not exacerbated by propranolol or labetalol.
    Steiner JA; Cooper R; Gear JS; Ledingham JG
    Br J Clin Pharmacol; 1979 Apr; 7(4):401-3. PubMed ID: 375960
    [No Abstract]   [Full Text] [Related]  

  • 2. A controlled trial of labetalol (Trandate), propranolol and placebo in the management of mild to moderate hypertension.
    Pugsley DJ; Nassim M; Armstrong BK; Beilin L
    Br J Clin Pharmacol; 1979 Jan; 7(1):63-8. PubMed ID: 367410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of labetalol and propranolol in hypertension.
    Nicholls DP; Husaini MH; Bulpitt CJ; Stephens MD; Butler AG
    Br J Clin Pharmacol; 1980 Mar; 9(3):233-7. PubMed ID: 6988003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenoceptor blocking drugs and cold feet in intermittent claudication.
    Lepäntalo M; Lindström BL; Tötterman KJ
    Vasa; 1986; 15(2):135-7. PubMed ID: 3727763
    [No Abstract]   [Full Text] [Related]  

  • 5. Controlled comparison of labetalol and propranolol in the management of severe hypertension.
    Pugsley DJ; Armstrong BK; Nassim MA; Beilin LJ
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):777-82. PubMed ID: 791331
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Labetalol and alprenolol. A comparative investigation of antihypertensive effect.
    Kofod P; Kjaer K; Vejlø S; Hvidt S
    Postgrad Med J; 1980; 56 Suppl 2():69-74. PubMed ID: 7001423
    [No Abstract]   [Full Text] [Related]  

  • 7. Postmarketing comparison of labetalol and propranolol in hypertensive patients.
    Due DL; Giguere GC; Plachetka JR
    Clin Ther; 1986; 8(6):624-31. PubMed ID: 3791361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raynaud's phenomenon caused by beta-receptor blocking drugs. Improvement after treatment with a combined alpha- and beta-blocker.
    Eliasson K; Danielson M; Hylander B; Lindblad LE
    Acta Med Scand; 1984; 215(4):333-9. PubMed ID: 6145298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of labetalol and propranolol in treatment of hypertension.
    Harvald B
    Postgrad Med J; 1980; 56 Suppl 2():65-8. PubMed ID: 7433346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Labetalol, beta blockers, and acute deterioration of chronic airway obstruction.
    Adam WR; Meagher EJ; Barter CE
    Clin Exp Hypertens A; 1982; 4(8):1419-28. PubMed ID: 6126285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind crossover clinical trial of labetalol and propranolol in patients of essential hypertension.
    Pandhi P; Aslam S; Sharma BK; Sharma PL; Wahi PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):101-4. PubMed ID: 3886563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Labetalol compared with propranolol in patients with both angina pectoris and systemic hypertension: a double-blind study.
    Frishman WH; Shapiro W; Charlap S
    J Clin Pharmacol; 1989 Jun; 29(6):504-11. PubMed ID: 2666451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of labetalol, hydrallazine, and propranolol in the therapy of moderate hypertension.
    West MJ; Wing LM; Mulligan J; Walkley J; Grygiel JJ; Graham JR; Chalmers JP
    Med J Aust; 1980 Mar; 1(5):224-5. PubMed ID: 6990215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Raynaud's phenomenon of the nipple associated with labetalol use.
    McGuinness N; Cording V
    J Hum Lact; 2013 Feb; 29(1):17-9. PubMed ID: 23212937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic effects of labetalol, pindolol, and propranolol on calf blood flow in intermittent claudication.
    Lepäntalo M
    Clin Pharmacol Ther; 1985 Jan; 37(1):7-12. PubMed ID: 3880687
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of different beta-blocking drugs on the peripheral circulation in Raynaud's phenomenon and in hypertension.
    Franssen C; Wollersheim H; de Haan A; Thien T
    J Clin Pharmacol; 1992 Jul; 32(7):652-9. PubMed ID: 1353506
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Haemodynamic effects of long-term oral labetalol.
    Edwards RC; Raftery EB
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):733-6. PubMed ID: 791328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Labetalol in the treatment of hypertension in patients with normal and impaired renal function.
    Walstad RA; Berg KJ; Wessel-Aas T; Nilsen OG
    Acta Med Scand Suppl; 1982; 665():135-41. PubMed ID: 6961760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antihypertensive effect and plasma levels of labetalol. A comparison with propranolol and dihydrallazine.
    Lehtonen A; Allonen H; Kleimola T
    Int J Clin Pharmacol Biopharm; 1979 Feb; 17(2):71-5. PubMed ID: 422304
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of blood pressure angiotensin II and aldosterone concentrations during treatment of severe hypertension with intravenous labetalol: comparison with propranolol.
    Trust PM; Rosei EA; Brown JJ; Fraser R; Lever AF; Morton JJ; Robertson JI
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):799-803. PubMed ID: 791333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.